ID   CNDP2_HUMAN             Reviewed;         475 AA.
AC   Q96KP4; B3KUG4; Q8WY59; Q9BQ94; Q9NVB4; V9HWE5;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   12-APR-2017, entry version 144.
DE   RecName: Full=Cytosolic non-specific dipeptidase;
DE            EC=3.4.13.18;
DE   AltName: Full=CNDP dipeptidase 2;
DE   AltName: Full=Carnosine dipeptidase II {ECO:0000303|PubMed:25964343};
DE   AltName: Full=Epididymis secretory protein Li 13 {ECO:0000312|EMBL:ACJ13654.1};
DE   AltName: Full=Glutamate carboxypeptidase-like protein 1;
DE   AltName: Full=Peptidase A;
GN   Name=CNDP2;
GN   Synonyms=CN2, CPGL, HEL-S-13 {ECO:0000312|EMBL:ACJ13654.1}, PEPA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 129-137; 276-289;
RP   311-329; 370-375 AND 462-474, CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12473676; DOI=10.1074/jbc.M209764200;
RA   Teufel M., Saudek V., Ledig J.P., Bernhardt A., Boularand S.,
RA   Carreau A., Cairns N.J., Carter C., Cowley D.J., Duverger D.,
RA   Ganzhorn A.J., Guenet C., Heintzelmann B., Laucher V., Sauvage C.,
RA   Smirnova T.;
RT   "Sequence identification and characterization of human carnosinase and
RT   a closely related non-specific dipeptidase.";
RL   J. Biol. Chem. 278:6521-6531(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT HIS-126.
RC   TISSUE=Uterus;
RA   Chen J.M., Barrett A.J.;
RT   "Cloning and sequencing of human glutamate carboxypeptidase homologue
RT   in peptidase family M20.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spleen, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-9; 54-66; 255-275 AND 403-430, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=17121880; DOI=10.1158/1078-0432.CCR-06-1307;
RA   Zhang P., Chan D.W., Zhu Y., Li J.J., Ng I.-O., Wan D., Gu J.;
RT   "Identification of carboxypeptidase of glutamate like-B as a candidate
RT   suppressor in cell growth and metastasis in human hepatocellular
RT   carcinoma.";
RL   Clin. Cancer Res. 12:6617-6625(2006).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19346245; DOI=10.1074/jbc.M808952200;
RA   Kaur H., Kumar C., Junot C., Toledano M.B., Bachhawat A.K.;
RT   "Dug1p Is a Cys-Gly peptidase of the gamma-glutamyl cycle of
RT   Saccharomyces cerevisiae and represents a novel family of Cys-Gly
RT   peptidases.";
RL   J. Biol. Chem. 284:14493-14502(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=24395568; DOI=10.2119/molmed.2013.00102;
RA   Zhang Z., Miao L., Xin X., Zhang J., Yang S., Miao M., Kong X.,
RA   Jiao B.;
RT   "Underexpressed CNDP2 participates in gastric cancer growth inhibition
RT   through activating the MAPK signaling pathway.";
RL   Mol. Med. 20:17-28(2014).
RN   [18]
RP   FUNCTION.
RX   PubMed=25964343; DOI=10.1073/pnas.1424638112;
RA   Jansen R.S., Addie R., Merkx R., Fish A., Mahakena S.,
RA   Bleijerveld O.B., Altelaar M., Ijlst L., Wanders R.J., Borst P.,
RA   van de Wetering K.;
RT   "N-lactoyl-amino acids are ubiquitous metabolites that originate from
RT   CNDP2-mediated reverse proteolysis of lactate and amino acids.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:6601-6606(2015).
CC   -!- FUNCTION: Hydrolyzes a variety of dipeptides including L-carnosine
CC       but has a strong preference for Cys-Gly (PubMed:19346245). Acts as
CC       a functional tumor suppressor in gastric cancer via activation of
CC       the mitogen-activated protein kinase (MAPK) pathway. An elevated
CC       level of CNDP2 activates the p38 and JNK MAPK pathways to induce
CC       cell apoptosis, and a lower level of CNDP2 activates the ERK MAPK
CC       pathway to promote cell proliferation (PubMed:24395568). Isoform 2
CC       may play a role as tumor suppressor in hepatocellular carcinoma
CC       (HCC) cells (PubMed:17121880). Catalyzes the production of N-
CC       lactoyl-amino acids from lactate and amino acids by reverse
CC       proteolysis (PubMed:25964343). {ECO:0000269|PubMed:17121880,
CC       ECO:0000269|PubMed:19346245, ECO:0000269|PubMed:24395568,
CC       ECO:0000269|PubMed:25964343}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of dipeptides, preferentially
CC       hydrophobic dipeptides including prolyl amino acids.
CC       {ECO:0000269|PubMed:12473676}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9D1A2};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000250|UniProtKB:Q9D1A2};
CC   -!- ENZYME REGULATION: Inhibited by p-hydroxymercurybenzoate. The
CC       inhibitory concentration 50% (IC(50)) is 13 uM. Inhibited by
CC       bestatin. The inhibitory concentration 50% (IC(50)) is 7 nM at pH
CC       9.5. {ECO:0000269|PubMed:12473676}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.04 mM for Ser-Gln (at pH 7.5 and in the presence of 0.1 mM
CC         manganese ions) {ECO:0000269|PubMed:12473676,
CC         ECO:0000269|PubMed:19346245};
CC         KM=0.6 mM for Cys-Gly (at pH 8.0 and in the presence of 50 uM
CC         manganese ions) {ECO:0000269|PubMed:12473676,
CC         ECO:0000269|PubMed:19346245};
CC         KM=15 mM for carnosine (at pH 9.5 and in the presence of 0.1 mM
CC         manganese ions) {ECO:0000269|PubMed:12473676,
CC         ECO:0000269|PubMed:19346245};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12473676}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12473676,
CC       ECO:0000269|PubMed:17121880}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96KP4-1; Sequence=Displayed;
CC       Name=2; Synonyms=CPGL-B;
CC         IsoId=Q96KP4-2; Sequence=VSP_038203;
CC         Note=Lacks a part of the catalytic domain. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed with
CC       higher levels in kidney and liver (at protein level). Expressed in
CC       peripheral blood leukocytes (PubMed:12473676). Isoform 2 is
CC       expressed in fetal tissues, it is only expressed in adult liver
CC       and placental tissues. Down-regulated in gastric cancer tissues
CC       (at protein level) (PubMed:24395568).
CC       {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:17121880,
CC       ECO:0000269|PubMed:24395568}.
CC   -!- MISCELLANEOUS: The reverse proteolysis is not negligible in vivo
CC       as long as the substrates are present in considerable
CC       concentrations, such as upon physical exercice. N-lac-Phe plasma
CC       levels are increased in patients with PKU with increased plasma
CC       Phe levels. N-lactoyl-amino acids are present in many tissues.
CC       {ECO:0000269|PubMed:25964343}.
CC   -!- SIMILARITY: Belongs to the peptidase M20A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AX523938; CAD56843.1; -; Unassigned_DNA.
DR   EMBL; AJ347717; CAC69883.1; -; mRNA.
DR   EMBL; AK001692; BAA91840.1; -; mRNA.
DR   EMBL; AK097155; BAG53426.1; -; mRNA.
DR   EMBL; AF258592; AAG23795.1; -; mRNA.
DR   EMBL; EU794600; ACJ13654.1; -; mRNA.
DR   EMBL; AC009704; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471117; EAW66551.1; -; Genomic_DNA.
DR   EMBL; CH471117; EAW66552.1; -; Genomic_DNA.
DR   EMBL; CH471117; EAW66554.1; -; Genomic_DNA.
DR   EMBL; BC001375; AAH01375.1; -; mRNA.
DR   EMBL; BC003176; AAH03176.1; -; mRNA.
DR   CCDS; CCDS12006.1; -. [Q96KP4-1]
DR   CCDS; CCDS54190.1; -. [Q96KP4-2]
DR   RefSeq; NP_001161971.1; NM_001168499.1. [Q96KP4-2]
DR   RefSeq; NP_060705.2; NM_018235.2. [Q96KP4-1]
DR   RefSeq; XP_005266785.1; XM_005266728.2. [Q96KP4-1]
DR   RefSeq; XP_006722566.1; XM_006722503.2. [Q96KP4-1]
DR   RefSeq; XP_011524373.1; XM_011526071.2. [Q96KP4-1]
DR   RefSeq; XP_011524374.1; XM_011526072.2. [Q96KP4-1]
DR   UniGene; Hs.149185; -.
DR   PDB; 4RUH; X-ray; 2.25 A; A/B=1-475.
DR   PDBsum; 4RUH; -.
DR   ProteinModelPortal; Q96KP4; -.
DR   SMR; Q96KP4; -.
DR   BioGrid; 120866; 47.
DR   IntAct; Q96KP4; 5.
DR   STRING; 9606.ENSP00000325548; -.
DR   MEROPS; M20.005; -.
DR   iPTMnet; Q96KP4; -.
DR   PhosphoSitePlus; Q96KP4; -.
DR   BioMuta; CNDP2; -.
DR   DMDM; 23396498; -.
DR   OGP; Q96KP4; -.
DR   EPD; Q96KP4; -.
DR   PaxDb; Q96KP4; -.
DR   PeptideAtlas; Q96KP4; -.
DR   PRIDE; Q96KP4; -.
DR   Ensembl; ENST00000324262; ENSP00000325548; ENSG00000133313. [Q96KP4-1]
DR   Ensembl; ENST00000324301; ENSP00000325756; ENSG00000133313. [Q96KP4-2]
DR   Ensembl; ENST00000579847; ENSP00000462311; ENSG00000133313. [Q96KP4-1]
DR   GeneID; 55748; -.
DR   KEGG; hsa:55748; -.
DR   UCSC; uc002llm.3; human.
DR   UCSC; uc002lln.3; human. [Q96KP4-1]
DR   CTD; 55748; -.
DR   DisGeNET; 55748; -.
DR   GeneCards; CNDP2; -.
DR   H-InvDB; HIX0136845; -.
DR   HGNC; HGNC:24437; CNDP2.
DR   HPA; CAB026196; -.
DR   HPA; HPA036898; -.
DR   HPA; HPA036899; -.
DR   MIM; 169800; gene.
DR   neXtProt; NX_Q96KP4; -.
DR   OpenTargets; ENSG00000133313; -.
DR   PharmGKB; PA134975242; -.
DR   eggNOG; KOG2276; Eukaryota.
DR   eggNOG; COG0624; LUCA.
DR   GeneTree; ENSGT00390000009682; -.
DR   HOGENOM; HOG000216709; -.
DR   HOVERGEN; HBG051103; -.
DR   InParanoid; Q96KP4; -.
DR   KO; K08660; -.
DR   OMA; VSDTGMW; -.
DR   OrthoDB; EOG091G05RU; -.
DR   PhylomeDB; Q96KP4; -.
DR   TreeFam; TF300633; -.
DR   BRENDA; 3.4.13.18; 2681.
DR   Reactome; R-HSA-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   SABIO-RK; Q96KP4; -.
DR   ChiTaRS; CNDP2; human.
DR   GenomeRNAi; 55748; -.
DR   PRO; PR:Q96KP4; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000133313; -.
DR   CleanEx; HS_CNDP2; -.
DR   ExpressionAtlas; Q96KP4; baseline and differential.
DR   Genevisible; Q96KP4; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0103046; F:alanylglutamate dipeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004180; F:carboxypeptidase activity; TAS:Reactome.
DR   GO; GO:0102008; F:cytosolic dipeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006750; P:glutathione biosynthetic process; TAS:Reactome.
DR   GO; GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome.
DR   CDD; cd05676; M20_dipept_like_CNDP; 1.
DR   InterPro; IPR001261; ArgE/DapE_CS.
DR   InterPro; IPR017153; CNDP/DUG1.
DR   InterPro; IPR002933; Peptidase_M20.
DR   InterPro; IPR011650; Peptidase_M20_dimer.
DR   Pfam; PF07687; M20_dimer; 1.
DR   Pfam; PF01546; Peptidase_M20; 1.
DR   PIRSF; PIRSF037242; CNDP_dipeptidase; 1.
DR   PROSITE; PS00759; ARGE_DAPE_CPG2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Carboxypeptidase;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Manganese; Metal-binding; Metalloprotease; Phosphoprotein;
KW   Polymorphism; Protease; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.9}.
FT   CHAIN         2    475       Cytosolic non-specific dipeptidase.
FT                                /FTId=PRO_0000185272.
FT   REGION      166    167       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    101    101       {ECO:0000250}.
FT   ACT_SITE    166    166       Proton acceptor. {ECO:0000250}.
FT   METAL        99     99       Manganese 2. {ECO:0000250}.
FT   METAL       132    132       Manganese 1. {ECO:0000250}.
FT   METAL       132    132       Manganese 2. {ECO:0000250}.
FT   METAL       167    167       Manganese 1. {ECO:0000250}.
FT   METAL       195    195       Manganese 2. {ECO:0000250}.
FT   METAL       445    445       Manganese 1. {ECO:0000250}.
FT   BINDING     195    195       Substrate; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   BINDING     228    228       Substrate; shared with homodimeric
FT                                partner. {ECO:0000250}.
FT   BINDING     330    330       Substrate; shared with homodimeric
FT                                partner. {ECO:0000250}.
FT   BINDING     343    343       Substrate. {ECO:0000250}.
FT   BINDING     417    417       Substrate; via amide nitrogen and
FT                                carbonyl oxygen. {ECO:0000250}.
FT   BINDING     445    445       Substrate. {ECO:0000250}.
FT   SITE        228    228       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      58     58       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6Q0N1}.
FT   MOD_RES     299    299       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      69    152       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_038203.
FT   VARIANT     126    126       Y -> H (in dbSNP:rs2278161).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_057154.
FT   CONFLICT    128    128       R -> G (in Ref. 4; BAA91840).
FT                                {ECO:0000305}.
FT   CONFLICT    348    348       M -> T (in Ref. 4; BAG53426).
FT                                {ECO:0000305}.
FT   HELIX         5     13       {ECO:0000244|PDB:4RUH}.
FT   HELIX        15     27       {ECO:0000244|PDB:4RUH}.
FT   STRAND       31     33       {ECO:0000244|PDB:4RUH}.
FT   HELIX        35     37       {ECO:0000244|PDB:4RUH}.
FT   HELIX        38     54       {ECO:0000244|PDB:4RUH}.
FT   STRAND       58     62       {ECO:0000244|PDB:4RUH}.
FT   STRAND       66     68       {ECO:0000244|PDB:4RUH}.
FT   STRAND       74     76       {ECO:0000244|PDB:4RUH}.
FT   STRAND       80     85       {ECO:0000244|PDB:4RUH}.
FT   STRAND       93     99       {ECO:0000244|PDB:4RUH}.
FT   HELIX       107    109       {ECO:0000244|PDB:4RUH}.
FT   STRAND      119    121       {ECO:0000244|PDB:4RUH}.
FT   STRAND      124    127       {ECO:0000244|PDB:4RUH}.
FT   TURN        128    133       {ECO:0000244|PDB:4RUH}.
FT   HELIX       134    149       {ECO:0000244|PDB:4RUH}.
FT   STRAND      155    164       {ECO:0000244|PDB:4RUH}.
FT   HELIX       166    168       {ECO:0000244|PDB:4RUH}.
FT   HELIX       173    180       {ECO:0000244|PDB:4RUH}.
FT   TURN        181    184       {ECO:0000244|PDB:4RUH}.
FT   STRAND      190    193       {ECO:0000244|PDB:4RUH}.
FT   STRAND      199    203       {ECO:0000244|PDB:4RUH}.
FT   STRAND      205    210       {ECO:0000244|PDB:4RUH}.
FT   STRAND      212    221       {ECO:0000244|PDB:4RUH}.
FT   HELIX       229    232       {ECO:0000244|PDB:4RUH}.
FT   TURN        233    235       {ECO:0000244|PDB:4RUH}.
FT   HELIX       239    247       {ECO:0000244|PDB:4RUH}.
FT   STRAND      259    261       {ECO:0000244|PDB:4RUH}.
FT   HELIX       284    289       {ECO:0000244|PDB:4RUH}.
FT   TURN        290    292       {ECO:0000244|PDB:4RUH}.
FT   HELIX       301    309       {ECO:0000244|PDB:4RUH}.
FT   STRAND      313    322       {ECO:0000244|PDB:4RUH}.
FT   STRAND      325    327       {ECO:0000244|PDB:4RUH}.
FT   STRAND      334    344       {ECO:0000244|PDB:4RUH}.
FT   HELIX       350    368       {ECO:0000244|PDB:4RUH}.
FT   STRAND      372    382       {ECO:0000244|PDB:4RUH}.
FT   HELIX       392    405       {ECO:0000244|PDB:4RUH}.
FT   STRAND      410    416       {ECO:0000244|PDB:4RUH}.
FT   HELIX       420    428       {ECO:0000244|PDB:4RUH}.
FT   STRAND      430    434       {ECO:0000244|PDB:4RUH}.
FT   STRAND      450    452       {ECO:0000244|PDB:4RUH}.
FT   HELIX       453    471       {ECO:0000244|PDB:4RUH}.
SQ   SEQUENCE   475 AA;  52878 MW;  43FA0668B0587A39 CRC64;
     MAALTTLFKY IDENQDRYIK KLAKWVAIQS VSAWPEKRGE IRRMMEVAAA DVKQLGGSVE
     LVDIGKQKLP DGSEIPLPPI LLGRLGSDPQ KKTVCIYGHL DVQPAALEDG WDSEPFTLVE
     RDGKLYGRGS TDDKGPVAGW INALEAYQKT GQEIPVNVRF CLEGMEESGS EGLDELIFAR
     KDTFFKDVDY VCISDNYWLG KKKPCITYGL RGICYFFIEV ECSNKDLHSG VYGGSVHEAM
     TDLILLMGSL VDKRGNILIP GINEAVAAVT EEEHKLYDDI DFDIEEFAKD VGAQILLHSH
     KKDILMHRWR YPSLSLHGIE GAFSGSGAKT VIPRKVVGKF SIRLVPNMTP EVVGEQVTSY
     LTKKFAELRS PNEFKVYMGH GGKPWVSDFS HPHYLAGRRA MKTVFGVEPD LTREGGSIPV
     TLTFQEATGK NVMLLPVGSA DDGAHSQNEK LNRYNYIEGT KMLAAYLYEV SQLKD
//
